Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis

B Vai, MG Mazza, CD Colli, M Foiselle, B Allen… - The Lancet …, 2021 - thelancet.com
Background Mental disorders might be a risk factor for severe COVID-19. We aimed to
assess the specific risks of COVID-19-related mortality, hospitalisation, and intensive care …

Polypharmacy among COVID-19 patients: A systematic review

S Iloanusi, O Mgbere, EJ Essien - Journal of the American Pharmacists …, 2021 - Elsevier
Background Polypharmacy, the concomitant use of 5 or more medications, is highly
prevalent among older adults and individuals with multimorbid conditions and has been …

Vaccine efficacy against severe COVID-19 in relation to delta variant (B. 1.617. 2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control …

PM McKeigue, DA McAllister, SJ Hutchinson… - The Lancet …, 2022 - thelancet.com
Background Reports have suggested that the efficacy of vaccines against COVID-19 might
have fallen since the delta (B. 1.617. 2) SARS-CoV-2 variant replaced the alpha (B. 1.1. 7) …

Identifying pre-existing conditions and multimorbidity patterns associated with in-hospital mortality in patients with COVID-19

M Bucholc, D Bradley, D Bennett, L Patterson… - Scientific reports, 2022 - nature.com
We investigated the association between a wide range of comorbidities and COVID-19 in-
hospital mortality and assessed the influence of multi morbidity on the risk of COVID-19 …

The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis

H Nakhaee, M Zangiabadian, R Bayati, M Rahmanian… - PLoS …, 2022 - journals.plos.org
Introduction Clinical Depression and the subsequent low immunity is a comorbidity that can
act as a risk factor for the severity of COVID-19 cases. Antidepressants such as Selective …

[HTML][HTML] Psychotropic drug repurposing for COVID-19: a systematic review and meta-analysis

G Fico, U Isayeva, M De Prisco, V Oliva, B Sole… - European …, 2023 - Elsevier
Several psychotropic drugs, including antidepressants (AD), mood stabilizers, and
antipsychotics (AP) have been suggested to have favorable effects in the treatment of …

The use of proton pump inhibitors and COVID-19: a systematic review and meta-analysis

K Fatima, T Almas, S Lakhani, A Jahangir… - Tropical Medicine and …, 2022 - mdpi.com
COVID-19 has proved to be a serious, and consequential disease that has affected millions
of people globally. Previously, the adverse effects of proton pump inhibitors (PPI) have been …

Prevalence of NSAID use among people with COVID‐19 and the association with COVID‐19‐related outcomes: Systematic review and meta‐analysis

H Zhao, S Huang, S Huang, F Liu… - British Journal of …, 2022 - Wiley Online Library
Aim Recent reports of potential harmful effects of nonsteroidal anti‐inflammatory drugs
(NSAIDs) in treating patients with coronavirus disease 2019 (COVID‐19) have raised great …

Global prevalence of polypharmacy among the COVID-19 patients: a comprehensive systematic review and meta-analysis of observational studies

H Ghasemi, N Darvishi, N Salari… - Tropical Medicine and …, 2022 - Springer
Background Polypharmacy has traditionally been defined in various texts as the use of 5 or
more chronic drugs, the use of inappropriate drugs, or drugs that are not clinically …

Understanding covid-19 outcomes among people with intellectual disabilities in England

F Sosenko, D Mackay, JP Pell, C Hatton, BD Jani… - BMC Public Health, 2023 - Springer
Background Evidence from the UK from the early stages of the covid-19 pandemic showed
that people with Intellectual Disabilities (ID) had higher rates of covid-19 mortality than …